<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02431949</url>
  </required_header>
  <id_info>
    <org_study_id>H14-02891</org_study_id>
    <nct_id>NCT02431949</nct_id>
  </id_info>
  <brief_title>The Music Study in Refractory Psychosis</brief_title>
  <acronym>MARS</acronym>
  <official_title>A Cross-sectional Analysis of Musical Ability in Patients With Refractory Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The perception of music requires coordinated neural activities in distributed&#xD;
      multi-functional centers across both hemispheres. The association between musical abilities&#xD;
      and other general cognitive functions have been studied in several populations with&#xD;
      inconsistent results.&#xD;
&#xD;
      Schizophrenia is a major mental disorder that is strongly associated with cognitive deficits.&#xD;
      These often appear before the onset of psychotic symptoms and persist throughout effective&#xD;
      treatment of positive and negative symptoms. Like other disorders of psychosis, schizophrenia&#xD;
      features general deficits in auditory memory and sensory processing. Recently, Sawada et al.&#xD;
      (2014) and Wen et al. (2014) studied music abilities in Japanese and Chinese schizophrenic&#xD;
      populations. They both used a standardized assessment for amusia called Montreal Battery of&#xD;
      Evaluation of Amusia (MBEA) and found marked impairments in perception of scale, contour,&#xD;
      interval, rhythm, meter and memory. Both studies showed that deficits in music perception&#xD;
      were associated with cognitive deficits and negative symptoms. In regards to positive&#xD;
      symptoms, Wen et al., but not Sawada et al., found a significant association.&#xD;
&#xD;
      The present clinical study will assess musical abilities using the MBEA in a Canadian&#xD;
      population with and without refractory psychosis. It will explore associations between&#xD;
      musical deficits, positive and negative psychiatric symptomology and cognition. The patient&#xD;
      population will have a diagnosis of schizophrenia, schizoaffective disorder, affective&#xD;
      disorder with psychosis or non substance-related psychosis who were referred to the British&#xD;
      Columbia Psychosis Program (BCPP) due to inadequate or no response to at least two trials of&#xD;
      antipsychotics. A focus on refractory psychosis may provide greater insights because these&#xD;
      patients have relatively more pronounced psychiatric symptoms and cognitive deficits. It will&#xD;
      also be valuable to administer the MBEA assessment on a Canadian population, because the test&#xD;
      was originally intended for Western populations and its musical phrases were designed with&#xD;
      Western tonalities.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. BACKGROUND, PURPOSE AND JUSTIFICATION&#xD;
&#xD;
           The perception of music requires coordinated neural activities in distributed&#xD;
           multi-functional centers across both hemispheres. The association between musical&#xD;
           abilities and other general cognitive functions have been studied in several populations&#xD;
           with inconsistent results.&#xD;
&#xD;
           Schizophrenia is a major mental disorder that is strongly associated with cognitive&#xD;
           deficits. These often appear before the onset of psychotic symptoms and persist&#xD;
           throughout effective treatment of positive and negative symptoms. Like other disorders&#xD;
           of psychosis, schizophrenia features general deficits in auditory memory and sensory&#xD;
           processing. Recently, Sawada et al. (2014) and Wen et al. (2014) studied music abilities&#xD;
           in Japanese and Chinese schizophrenic populations. They both used a standardized&#xD;
           assessment for amusia called Montreal Battery of Evaluation of Amusia (MBEA) and found&#xD;
           marked impairments in perception of scale, contour, interval, rhythm, meter and memory.&#xD;
           Both studies showed that deficits in music perception were associated with cognitive&#xD;
           deficits and negative symptoms. In regards to positive symptoms, Wen et al., but not&#xD;
           Sawada et al., found a significant association.&#xD;
&#xD;
           The present clinical study will assess musical abilities using the MBEA in a Canadian&#xD;
           population with and without refractory psychosis. It will explore associations between&#xD;
           musical deficits, positive and negative psychiatric symptomology and cognition. The&#xD;
           patient population will have a diagnosis of schizophrenia, schizoaffective disorder,&#xD;
           affective disorder with psychosis or non substance-related psychosis who were referred&#xD;
           to the British Columbia Psychosis Program (BCPP) due to inadequate or no response to at&#xD;
           least two trials of antipsychotics. A focus on refractory psychosis may provide greater&#xD;
           insights because these patients have relatively more pronounced psychiatric symptoms and&#xD;
           cognitive deficits. It will also be valuable to administer the MBEA assessment on a&#xD;
           Canadian population, because the test was originally intended for Western populations&#xD;
           and its musical phrases were designed with Western tonalities.&#xD;
&#xD;
        2. RESEARCH OUTLINE This is a cross-sectional, observational study. Participating patients&#xD;
           with refractory psychosis and healthy (age- and gender- matched) controls will undergo&#xD;
           the Montreal Battery of Evaluation of Amusia assessment and assessments of cognition and&#xD;
           symptoms.&#xD;
&#xD;
      The purpose of the study is to describe music perceptive ability in patients with refractory&#xD;
      psychosis using the Montreal Battery of Evaluation of Amusia, a standardized and continuous&#xD;
      measure of musical ability. The criterion for amusia is a score of 2 standard deviations&#xD;
      below the mean of normal participants.&#xD;
&#xD;
      4) OBJECTIVES&#xD;
&#xD;
      Primary:&#xD;
&#xD;
      The primary objective is to compare music perceptive ability in patients with clinically&#xD;
      identified refractory psychosis with healthy subjects.&#xD;
&#xD;
      Secondary:&#xD;
&#xD;
      The secondary objectives are to compare the prevalence of amusia in a population of patients&#xD;
      with refractory psychosis versus a population of healthy controls, and to compare psychiatric&#xD;
      symptoms and cognition in patients with amusia versus patients without amusia. We will also&#xD;
      determine if an association exists between music perceptive ability and:&#xD;
&#xD;
        -  General and specific aspects of symptom severity, as assessed by standardized symptom&#xD;
           rating scales and neurological status examination.&#xD;
&#xD;
        -  General and specific aspects of cognition, as assessed by cognitive tests.&#xD;
&#xD;
        -  Demographic variables such as sex, age, musical training and education. In addition, we&#xD;
           will investigate potential pathways between symptomologies of psychosis, cognitive&#xD;
           deficits and musical disability (if found) by using exploratory mediation analysis.&#xD;
&#xD;
           5) RESEARCH METHOD We will recruit 100 participants, who will undergo the Montreal&#xD;
           Battery of Evaluation of Amusia test and cognitive tests. Of these, 50 will be age- and&#xD;
           gender- matched participants not diagnosed with a psychosis disorder who will serve as&#xD;
           controls. The remaining 50 participants will be recruited from BCPP at UBC Hospital for&#xD;
           in-patients diagnosed with refractory psychosis. For patients, participation will also&#xD;
           involve assessments of their mental health (psychiatric symptoms).&#xD;
&#xD;
           6) STATISTICAL ANALYSIS Inferential analyses will be used to assess differences in&#xD;
           musical ability between patients and controls. It will also be used to evaluate&#xD;
           differences in psychiatric symptoms and cognition between patients with amusia and those&#xD;
           without amusia. Linear regression analyses will be done to relate psychiatric symptoms&#xD;
           and cognition to musical ability. Mediation analyses will be performed to determine a&#xD;
           causal model between symptoms, cognition and musical ability.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>2 Weeks</target_duration>
  <primary_outcome>
    <measure>Musical Ability (The Montreal Battery of Evaluation of Amusia)</measure>
    <time_frame>2 hours</time_frame>
    <description>Assessment of musical ability based on scores from The Montreal Battery of Evaluation of Amusia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive Ability (NIH toolbox-cognitive battery scores)</measure>
    <time_frame>1 hour</time_frame>
    <description>NIH toolbox-cognitive battery scores.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mental Health Symptom Severity (Rating scales from Sci-PANSS and MINI Neuropsychiatric Interview)</measure>
    <time_frame>2 hours</time_frame>
    <description>Rating scales from Sci-PANSS and MINI Neuropsychiatric Interview.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Psychosis</condition>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Participants without a psychosis disorder diagnosis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
    <description>Participants with a psychosis disorder diagnosis- recruited from the BC Psychosis Program.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Admission to BCPP</intervention_name>
    <description>There is no intervention associated with this study.</description>
    <arm_group_label>Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The participant population will include all patients who have been admitted to the British&#xD;
        Columbia Psychosis Progarm (BCPP) at the University of British Columbia (UBC) Hospital.&#xD;
        Admission criteria to BCPP include the following: 1) Must be 18 years or older who are&#xD;
        medically stable; 2) Diagnosis of schizophrenia, schizoaffective disorder, mood disorder&#xD;
        with psychosis, or non-substance-related psychosis requiring diagnostic clarification; 3)&#xD;
        History of no response or inadequate response of positive symptoms to at least 2 adequate&#xD;
        trials of antipsychotics (one of which is a second generation agent) by health authority&#xD;
        tertiary clinical teams; 4) Incomplete recovery of social, vocational, and occupational&#xD;
        functioning likely to respond to active intervention. Control subjects will be age and&#xD;
        gender matched with patient participants.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Admission to BC Psychosis Program at UBC Hospital in Vancouver, B.C. with a diagnosis&#xD;
             of a psychosis disorder (patients only)&#xD;
&#xD;
          -  Fluency in English (patients and controls)&#xD;
&#xD;
          -  Able to give consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        For controls and patients:&#xD;
&#xD;
        â€¢ Presence of hearing deficits&#xD;
&#xD;
        For controls only, history of:&#xD;
&#xD;
          -  Diagnosis of psychosis disorder&#xD;
&#xD;
          -  Antipsychotic medications&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alasdair Barr, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of British Columbia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sujin Im, BSc</last_name>
    <phone>778-899-5969</phone>
    <email>sujinim92@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Delrae Fawcett, MSc</last_name>
    <phone>604-349-8982</phone>
    <email>delrae.fawcett@ubc.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>BC psychosis ward at UBC Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delrae Fawcett</last_name>
      <phone>604-875-2000 x6115</phone>
      <email>delrae.fawcett@ubc.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <study_first_submitted>April 28, 2015</study_first_submitted>
  <study_first_submitted_qc>April 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 1, 2015</study_first_posted>
  <last_update_submitted>May 24, 2016</last_update_submitted>
  <last_update_submitted_qc>May 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Music</keyword>
  <keyword>Amusia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

